Rosiglitazone Intervention Study in Patients With Type 1.5 Diabetes.
Latest Information Update: 04 Jul 2023
At a glance
- Drugs Rosiglitazone (Primary) ; Glibenclamide
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 13 Jul 2011 Official Title amended as reported by ClinicalTrials.gov.
- 14 Apr 2009 Actual end date (Dec 2008), actual patient number (65), additional lead centres added as reported by ClinicalTrials.gov.
- 14 Apr 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.